| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | CEO And President | See Remarks
1 company
Kumar Neil serves as a Chief Executive Officer at BBIO. Across recent SEC filings that breaks down to 0 buys and 216 sells. Those positions are worth an estimated $34.3M at current prices.
Historically, Kumar Neil's trades have earned a below-average insider score of 31/100 across 40 rated trades. Over a 12-month horizon, 9.1% of those trades were profitable, with an average 12-month return of -85.0%.
The biggest single holding is BBIO (~$34.3M) as Chief Executive Officer. The recent filings there lean toward selling, a net 4,118,030 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 75,000 | $34.11 | $2,558,025.00 | -1.5% | +34.3% | - | |
| Mar 25, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 75,000 | $36.87 | $2,764,942.50 | -1.5% | +14.8% | +94.9% | |
| Feb 25, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 75,000 | $33.57 | $2,517,971.14 | -1.5% | -3.6% | +94.0% | |
| Feb 19, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sale+OE | 31,543 | $36.14 | $1,140,024.26 | -13.0% | -7.1% | +94.9% | |
| Jan 29, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 600,000 | $36.31 | $21,788,650.42 | -10.5% | -0.1% | +117.0% | |
| Nov 19, 2024 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 27,389 | $22.41 | $613,825.89 | -0.6% | +57.5% | +190.8% | |
| Aug 19, 2024 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sale+OE | 27,389 | $24.69 | $676,256.05 | -0.6% | -11.2% | +94.3% | |
| Nov 17, 2023 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sale+OE | 51,552 | $29.10 | $1,500,037.52 | -1.1% | +34.1% | -18.9% | |
| Aug 17, 2023 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sale+OE | 51,552 | $28.59 | $1,473,784.04 | -1.1% | +3.9% | -14.1% | |
| May 17, 2023 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sale+OE | 51,552 | $14.01 | $722,217.74 | -1.1% | +116.3% | +120.5% |